Miracle! Cancer Vanishes For Every Patient In Drug - Dostarlimab

 DOSTARLIMAB

- Dostarlimab is an monoclonal antibody drug . 

• 18 rectal cancer patients who received dostalimab drug have completely been cure
• They received prescribed doses for six months.

• The clinical trial consisted of a group of 18 patients and surprisingly all of them were cured using the drug
• They were all battling rectal cancer at the Memorial Sloan Kettering Cancer Center in Manhattan , US
• The cancer was locally advanced meaning the tumors were already spread within the rectum and to the regional lymph nodes but not to other organs

The drug named Dostarlimab was given to the volunteers for six months in prescribed dosages which was every three weeks.At the end of the trial, cancer was checked for and remained undetected through physical exam and endoscopy , PET scans, or MRI Scans which was a miracle in itself because none of the patients had any tumor cells.

 The cost of the medicine is 11,000 dollars which is really very expensive but it can be a way through to other cheaper versions of it in the near future.The medicine works by unmasking the cancer cells which in turn assist the immune system to identify and destroy those cells

 The clinical trial was conducted by a team led by Dr, Luis A. Diaz Jr. in 2017

Those patients that were part of the study were already undergone previous treatments to manage their cancer which includes chemotherapy, radiation, and invasive surgery.After the trial, they did not have to take painful chemotherapy and radiation sessions now.The good thing is that it showed a complete absence of significant post treatment complications as well any signs of recurrence of cancer in the patients until 25 months from the end of trial.

The study was sponsored by the drug company GlaxoSmithKline.